Part,  Chapter, Paragraph

 1   II,     5.  4.  2| Prevalence of diabetes mellitus/1000 population ~15~HIS/HES/SPSN/
 2   II,     5.  4.  2|   present in the population per 1000 individuals in that population
 3   II,     5.  4.  2|        with values all over 100/1000 for EUCID participating
 4   II,     5.  4.  2|    reporting a range between 40/1000 (UK) and 118/1000 (Germany),
 5   II,     5.  4.  2|    between 40/1000 (UK) and 118/1000 (Germany), and a median
 6   II,     5.  4.  2|  Germany), and a median of 87.5/1000. These different results,
 7   II,     5.  4.  3|       by EUCID range between 26/1000 (Finland) and 76/1000 (Cyprus),
 8   II,     5.  4.  3|        26/1000 (Finland) and 76/1000 (Cyprus), with a median
 9   II,     5.  4.  3|           with a median of 30.5/1000.~According to the IDF data
10   II,     5.  5.Int|          prevalence 4.5-5.0 per 1000), 1.9 million aged 20-64 (
11   II,     5.  5.Int|       20-64 (prevalence six per 1000) and 0.6 million aged 65
12   II,     5.  5.Int|     older (prevalence seven per 1000). Approximately 20-30% of
13   II,     5.  5.  3|    point prevalence was 4.6 per 1000, period prevalence 3.3 per
14   II,     5.  5.  3|       period prevalence 3.3 per 1000, lifetime prevalence 4.0
15   II,     5.  5.  3|     lifetime prevalence 4.0 per 1000 and lifetime morbid risk
16   II,     5.  5.  3|    lifetime morbid risk 7.2 per 1000, respectively. Based on
17   II,     5.  5.  3|     Mental Health Report, 7 per 1000 suffer from schizophrenia
18   II,     5.  5.  3|       emerging based on DDD per 1000 inhabitants per day. Compilation,
19   II,     5.  5.  3|  in-patient admission rates per 1000; Main diagnosis: Schizophrenia
20   II,     5.  5.  3|      WHO European Region (7 per 1000) affected by schizophrenia
21   II,     5.  6.  3|  replacement is 27.4 joints per 1000 people aged 35 or more according
22   II,     5.  6.  3|        of RA range from 1-6 per 1000 for men and 3-12 per 1000
23   II,     5.  6.  3|       1000 for men and 3-12 per 1000 for women. In all studies
24   II,     5.  6.  3|    incidence of 28.0 episodes / 1000 people per year; the incidence
25   II,     5.  6.  3|        with sciatica was 11.6 / 1000 people per year, affecting
26   II,     5.  7.  3|     rate of 3-5 CKD was 7.8 per 1000 patients x years (Kurella
27   II,     5.  7.  3|     developed in 1983 for every 1000 prevalent patients with
28   II,     5.  7.  3|     developed in 1996 for every 1000 patients with CKD in 1991.
29   II,     5.  9.  3|         to 2000 period was 2.56/1000 people per year. Incidence
30   II,     5.  9.  3|        less than 10 years (4.38/1000 people per year) and in
31   II,     5.  9.  3|      women aged 30 or more (3.1/1000 people per year) and showed
32   II,     5.  9.  4|        among females (2.9 cases.1000 person-yrs(-1)) than among
33   II,     5.  9.  4|     than among males (1.5 cases.1000 person-yrs(-1)). (Torén
34   II,     5. 15.  3|       Italian registries, 5 per 1000, can only be considered
35   II,     8.  2.  3|     amount, in 2001, to 4.6 YLD/1000 (males) and 4.3 YLD/1000 (
36   II,     8.  2.  3|        1000 (males) and 4.3 YLD/1000 (females) in the WHO EURO
37   II,     8.  2.  3|       WHO EURO A and to 3.3 YLD/1000 (males and females) in the
38   II,     9.  1.  1|   gestation in a given year per 1000 live and stillbirths in
39   II,     9.  1.  1|        be presented for infants 1000 or more.~EURO-PERISTAT recommends
40   II,     9.  1.  1|       given year, expressed per 1000 live births in the same
41   II,     9.  1.  1|        given year expressed per 1000 live births in the same
42   II,     9.  1.  1|      the group of children born 1000-1499g (Platt et al, 2007).~ ~
43   II,     9.  3.  1|          prevalence 4.55.0 per 1000), 1.9 million aged 2064 (
44   II,     9.  3.  1|          prevalence about 6 per 1000) and 0.6 million aged 65
45   II,     9.  3.  1|          prevalence about 7 per 1000). Approximately 2030% of
46   II,     9.  3.  2|       ranges from about 150 per 1000 live births to 300 per 1000
47   II,     9.  3.  2|     1000 live births to 300 per 1000 live births. This practice
48  III,    10.  2.  1|       between 1 and 8 cases per 1000 inhabitants aged 15-64.~ ~
49  III,    10.  2.  1|        estimate of 15 cases per 1000 has been reported. Extrapolation
50  III,    10.  2.  1|       of Clinical Nutrition 58, 1000-1010~Greece~Data not available~ ~ ~ ~ ~
51  III,    10.  4.  3|         is in the range 1/100-1/1000 (Vahter et al, 2006). At
52  III,    10.  5.  1|      levels of CO2 ranging from 1000-4000 ppm (Kim et al, 2007;
53  III,    10.  5.  3|    morbidity (i.e. 591 days per 1000 population) at a cost of €
54  III,    10.  5.  3|         is twice in men (80 per 1000,000) compared to women.
55  III,    10.  5.  3|      migration rate was 2.8 per 1000 pople in EU25. The First
56  III,    10.  6.  1|         sample sizes were about 1000 per country/region, except
57   IV,    11.  1.  3|    countries spend less than US$1000 per capita on healthcare,